Tilray CEO: Alternatives in medical cannabis are astronomical
Tilray’s stock is up this day, nonetheless still down 80 p.c from a February excessive. CNBC’s Frank Holland experiences on his dialog with Tilray CEO Irwin Simon relating to the…
Read more »